INTECH Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$988K Buy
10,294
+3,118
+43% +$320K 0.01% 1038
2026
Q1
$783K Sell
7,176
-7,601
-51% -$724K 0.01% 1113
2025
Q4
$1.2M Buy
14,777
+75
+0.5% +$6.46K 0.01% 1020
2025
Q3
$1.29M Sell
14,702
-1,830
-11% -$163K 0.01% 1045
2025
Q2
$1.37M Sell
16,532
-4,435
-21% -$371K 0.01% 1011
2025
Q1
$1.76M Buy
20,967
+11,288
+117% +$1.05M 0.02% 835
2024
Q4
$892K Buy
9,679
+5,619
+138% +$540K 0.01% 1223
2024
Q3
$377K Buy
+4,060
New +$352K ﹤0.01% 1380

Other funds holding LMAT

INTECH Investment Management's LMAT Position: Q2 2026 in Review

INTECH Investment Management increased its LeMaitre Vascular (LMAT) stake by 43% in Q2 2026, buying an estimated $320K and bringing the position to 10,294 shares worth $988K. The position accounts for 0.01% of the portfolio, ranked #1038.

INTECH Investment Management first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.76M in Q1 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • INTECH Investment Management held 10,294 shares of LeMaitre Vascular worth $988K as of Q2 2026.
  • INTECH Investment Management bought 3,118 LeMaitre Vascular shares in Q2 2026, an estimated $320K.
  • LeMaitre Vascular made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1038 holding.
  • INTECH Investment Management first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's LeMaitre Vascular position peaked at $1.76M in Q1 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.